Anavex Life Sciences Corp (AVXL)

[boi568]

That's a remarkable attitude.

Let's say that Anavex reports all endpoints met, AF publishes some bogus attack, and the stock drops that day. You say you have been holding since 2015, but in this case you would sell half your shares rather than wait out a short attack. Do you think the share price would remain down on a successful AD 2b/3 trial? Do you think the company's decision to submit an NDA, or the FDA's decision on the application will be determined by a bogus short attack? And you have held, you say, for seven years for these kind of trial results? This doesn't add up.